These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7820046

  • 1. Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
    di Celle PF, Reato G, Raspadori D, Carbone A, Rondelli D, Lauria F, Foà R.
    Leuk Lymphoma; 1994; 14 Suppl 1():139-42. PubMed ID: 7820046
    [Abstract] [Full Text] [Related]

  • 2. New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine.
    Schirmer M, Haun M, Grünewald K, Geisen F, Hilbe W, Thaler J, Konwalinka G.
    Acta Haematol; 2000; 103(2):109-11. PubMed ID: 10838455
    [Abstract] [Full Text] [Related]

  • 3. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
    Robak T, Błasińska-Morawiec M, Błoński J, Hellmann A, Hałaburda K, Konopka L, Kotlarek-Haus S, Potoczek S, Hansz J, Dmoszyńska A, Urasiński I, Zdziarska B, Dwilewicz-Trojaczek J, Hołowiecki J, Skotnicki AB.
    Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
    [Abstract] [Full Text] [Related]

  • 4. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J.
    Blood Cells Mol Dis; 1995 Jan; 21(2):142-51. PubMed ID: 8846043
    [Abstract] [Full Text] [Related]

  • 5. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN, Cazals-Hatem D, Daniel MT, D'Agay MF, Rabian C, Glaisner S, Noel-Walter MP, Dabout D, Flandrin G, Dombret H, Poisson D, Degos L, Castaigne S.
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cladribine in hairy cell leukemia.
    Belani R, Saven A.
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
    Pawelski S.
    Acta Haematol Pol; 1995 Oct; 26(2):139-43. PubMed ID: 7653218
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O, Tomová A, Kusenda J, Gyárfás J.
    Neoplasma; 2001 Oct; 48(5):350-7. PubMed ID: 11845978
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index.
    Tallman MS, Hakimian D, Dyrda S, Kiley C, Nemcek A, Peterson L.
    Leuk Lymphoma; 1994 Oct; 14 Suppl 1():133-8. PubMed ID: 7529609
    [Abstract] [Full Text] [Related]

  • 14. A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission.
    Filleul B, Delannoy A, Ferrant A, Zenebergh A, Van Daele S, Bosly A, Doyen C, Mineur P, Glorieux P, Driesschaert P.
    Leukemia; 1994 Jul; 8(7):1153-6. PubMed ID: 7913513
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U, Gawaz M, Grunewald R, Hill W, Lorenz B, Stôtzer O.
    Anticancer Res; 1993 Jul; 13(5C):1809-14. PubMed ID: 7903521
    [Abstract] [Full Text] [Related]

  • 16. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
    Jehn U, Bartl R, Dietzfelbinger H, Haferlach T, Heinemann V.
    Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Lauria F, Benfenati D, Raspadori D, Rondelli D, Zinzani PL, Tura S.
    Leuk Lymphoma; 1993 Nov; 11(5-6):399-404. PubMed ID: 7907247
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.